Jackson Creek Investment Advisors LLC Catalent, Inc. Transaction History

Jackson Creek Investment Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$87.2 - $114.05 $2,964 - $3,877	-34 Reduced 0.59%	5,739 $649,000
Q1 2022 May 03, 2022	BUY	$94.19 - $124.49 $543,758 - $718,680	5,773 New	5,773 $640,000
Q2 2021 Aug 03, 2021	SELL	$100.34 - $115.69 $267,004 - $307,851	-2,661 Closed	0 $0
Q1 2021 May 27, 2021	SELL	$101.51 - $125.27 $5,786 - $7,140	-57 Reduced 2.1%	2,661 $280,000
Q4 2020 Feb 03, 2021	SELL	$85.88 - $105.36 $1,545 - $1,896	-18 Reduced 0.66%	2,718 $283,000
Q3 2020 Nov 09, 2020	BUY	$72.74 - $92.5 $199,016 - $253,080	2,736 New	2,736 $234,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.